Bromelain Inhibitory Effect on Colony Formation: An

Bromelain colony formation assay human cancer cells

Journal

Journal of medical signals and sensors
ISSN: 2228-7477
Titre abrégé: J Med Signals Sens
Pays: India
ID NLM: 101577416

Informations de publication

Date de publication:
Historique:
received: 23 09 2018
revised: 01 06 2019
accepted: 19 06 2019
entrez: 19 11 2019
pubmed: 19 11 2019
medline: 19 11 2019
Statut: epublish

Résumé

Bromelain is dotted with anticancer properties on various cancer cell lines. Anticancer pathways of bromelain, as well related intervening signalization are under investigation. Investigating the inhibitory potential of bromelain on AGS, PC3, and MCF7 cells proliferation and colony formation. The bromelain inhibitory potential on AGS, PC3, and MCF7 cells proliferation at various bromelain concentrations was assessed by MTT; thereby, bromelain potency on colony formation impediment was evaluated using clonogenic assays at determined 50% inhibitory concentrations (IC

Identifiants

pubmed: 31737556
doi: 10.4103/jmss.JMSS_42_18
pii: JMSS-9-267
pmc: PMC6839443
doi:

Types de publication

Journal Article

Langues

eng

Pagination

267-273

Informations de copyright

Copyright: © 2019 Journal of Medical Signals & Sensors.

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Références

Biochim Biophys Acta. 2016 Dec;1866(2):300-319
pubmed: 27742530
J Vis Exp. 2011 Mar 13;(49):null
pubmed: 21445039
J Med Food. 2012 Apr;15(4):344-9
pubmed: 22191568
J Natl Cancer Inst. 2015 Mar 31;107(7):null
pubmed: 25828948
Radiol Oncol. 2012 Sep;46(3):226-32
pubmed: 23077461
Adv Cancer Res. 2012;115:221-63
pubmed: 23021246
CA Cancer J Clin. 2014 Jul-Aug;64(4):252-71
pubmed: 24890451
Sci Rep. 2017 Jul 10;7(1):4930
pubmed: 28694503
Onco Targets Ther. 2013 Apr 16;6:403-9
pubmed: 23620673
Neoplasia. 2001 Nov-Dec;3(6):469-79
pubmed: 11774029
Prostate. 2011 Nov;71(15):1668-79
pubmed: 21432867
Clin Diagn Lab Immunol. 2004 Jan;11(1):63-9
pubmed: 14715546
Br J Cancer. 2018 Jan;118(2):189-199
pubmed: 29136407
J Exp Clin Cancer Res. 2014 Nov 12;33:92
pubmed: 25425315
Biofactors. 2010 Nov-Dec;36(6):474-82
pubmed: 20848558
Nature. 2008 Jul 24;454(7203):436-44
pubmed: 18650914
Cancer Lett. 2010 Apr 28;290(2):148-56
pubmed: 19700238
Integr Med Res. 2017 Jun;6(2):141-148
pubmed: 28664137
Anticancer Drugs. 2014 Feb;25(2):150-60
pubmed: 24366282

Auteurs

Farzane Raeisi (F)

Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Elham Raeisi (E)

Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Department of Medical Physics and Radiology, School of Allied Medical Sciences, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Esfandiar Heidarian (E)

Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Daryoush Shahbazi-Gahroui (D)

Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Yves Lemoigne (Y)

Department of Medical Physic, IFMP, Ambilly, France.

Classifications MeSH